Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) also known as Liver cancer is a primary malignancy disorder of the liver occurring primarily in patients with chronic hepatitis and other liver diseases. Hepatocellular carcinoma is the 3rd major leading cause of cancer-related deaths globally. The common symptoms are yellowish skin, severe abdominal swelling and pain, loss of appetite, weight loss, nausea, vomiting, and fatigue. People with chronic Hepatitis B and/ hepatitis C, patients with history of alcohol abuse, presence of aflatoxins, people with hemochromatosis, or with non-alcoholic steatohepatitis, type 2 diabetes, Wilson’s diseases, and Hemophilia, are at high risk of liver cancer. Treatment methods include surgical re-section, where surgeons remove the part of the liver having tumor while trying to preserve the healthy liver tissue. This method is not always desirable because only about 15% people globally are eligible for resection. Other most common treatment method is liver transplant. But, owing to the shortage of the organ with increasing list of patients for transplant, this option is not always recommended. The most common therapies prescribed by doctors are the Ablative therapies, viz., radiofrequency ablation (RFA), Cryo-ablation, Per-cutaneous ethanol injection, portal vein embolization, and potentially novel chemotherapeutic agents. These therapies help the patients in relieving the symptoms and provide relief. 

  • Liver diseases
  • Liver cirrhosis
  • Diabetes mellitus
  • Hepatic Screening and Imaging
  • Hepatic Pathology
  • Hepatic resection
  • Liver transplantation
  • Ablation therapies
  • Portal Vein Embolization

Related Conference of Hepatocellular Carcinoma

April 24-25, 2019

International Conference on Gastroenterology and Hepatology

Novotel Budapest City, Budapest, Hungary.
April 24-25, 2019

International conference on Liver and Hepatitis

Novotel Budapest City, Budapest, Hungary
July 08-09-2019

14th Euro-Global Gastroenterology Conference

Zurich, Switzerland
July 15-16, 2019

7th International Conference on Hepatology

Sydney, Australia
September 23-24, 2019

2nd World Summit on Liver Cirrhosis and Hepatitis

Tokyo, Japan
October 14-15, 2019

19th World Gastroenterologists Summit

Sydney, Australia
October 23-24, 2019 |

World Congress on Pancreatic Cancer and Liver Diseases

Tokyo, Japan

Hepatocellular Carcinoma Conference Speakers

Recommended Sessions

Related Journals

Are you interested in